Solvonis Therapeutics (SVNS)

Sector:

Pharma and Biotech

0.095p
   
  • Change Today:
    -0.010p
  • 52 Week High: 0.34
  • 52 Week Low: 0.093
  • Currency: UK Pounds
  • Shares Issued: 7,900m
  • Volume: 63,381,564
  • Market Cap: £7.50m
  • Beta: 0.02

SVNS Overview

Our motto “COMBINE INCOMPATIBLE” defines the essence of our business which is to create polymer modifiers & alloys which combine immiscible and incompatible components of polymers to achieve a versatile range of mechanical characteristics including good impact and chemical resistance, fire retardant properties and cost-effectiveness.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 1.8  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

SVNS Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 0.22 (0.95) (1.36)p n/a n/a n/a n/a 0.0%
31-Dec-22 0.54 (2.70) (2.61)p n/a n/a n/a n/a 0.0%
31-Dec-23 0.59 (3.12) (3.00)p n/a n/a n/a n/a 0.0%
31-Dec-24 n/a (1.45) (0.13)p n/a n/a n/a n/a 0.0%
31-Dec-25 n/a (5.74) (0.12)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

SVNS Company Announcements

Holding(s) in Company 16-Oct-2026 11:18 RNS
MOU Reached with ICAD 13-Oct-2026 07:00 RNS
Notification of Admission of Shares and TVR 30-Sep-2026 12:06 RNS

SVNS ShareCast News

SVN-114 selected for PTSD discovery programme 10-Mar-2026 ShareCast
Research and Development Update – Q4 2025 22-Dec-2025 ShareCast
Graft Polymer to buy Awakn in £4.98m deal 16-Dec-2024 ShareCast

Latest SVNS Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

SVNS Market Data

Currency UK Pounds
Share Price 0.095p
Change Today -0.010p
% Change -9.52 %
52 Week High 0.34
52 Week Low 0.093
Volume 63,381,564
Shares Issued 7,900m
Market Cap £7.50m
Beta 0.02

SVNS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
17.24% below the market average17.24% below the market average17.24% below the market average17.24% below the market average17.24% below the market average
Sector averageSector averageSector averageSector averageSector average
Price Trend
37.67% below the market average37.67% below the market average37.67% below the market average37.67% below the market average37.67% below the market average
16.28% below the sector average16.28% below the sector average16.28% below the sector average16.28% below the sector average16.28% below the sector average
Income Not Available
Growth Not Available

SVNS Dividends

No dividends found

Trades for 22-Oct-2026

Time Volume / Share Price
16:42 10,000,000 @ 0.100p
16:26 5,000,009 @ 0.093p
16:26 3,256,513 @ 0.100p
16:24 1,056,611 @ 0.095p
16:21 3,768,844 @ 0.100p

SVNS Key Personnel

CEO Anthony Tennyson
Chair Dennis Purcell

Top of Page